STOCKWATCH
·
Biotechnology: Pharmaceutical Preparations
AcquisitionsMay 14, 2026, 04:40 PM

Prestige Consumer to Acquire Breathe Right & Dimetapp Brands

AI Summary

Prestige Consumer Healthcare Inc. is an OTC health and personal care products company operating in North American and International segments. The company has a definitive agreement to acquire the Breathe Right and Dimetapp brands from Foundation Consumer Brands, LLC, anticipated to close in the first half of fiscal 2027. In fiscal 2026, its North American OTC Healthcare segment represented 83.9% of net revenues, while major brands contributed 83.5% of total revenues, with 63.7% from #1 market position brands.

Key Highlights

  • Entered definitive agreement to acquire Breathe Right and Dimetapp brands, closing H1 fiscal 2027.
  • Acquired Pillar5 Pharma Inc., a sterile ophthalmic manufacturer, in fiscal 2026.
  • North American OTC Healthcare segment comprised 83.9% of net revenues in fiscal 2026.
  • International OTC Healthcare segment comprised 16.1% of net revenues in fiscal 2026.
  • Major brands accounted for 83.5% of total revenues in fiscal 2026.
  • 63.7% of total revenues in fiscal 2026 were from #1 market position brands.
  • Walmart accounted for approximately 20% of gross revenues in fiscal 2026.
  • Amazon accounted for approximately 15% of gross revenues in fiscal 2026.
PBH
Biotechnology: Pharmaceutical Preparations
Prestige Consumer Healthcare Inc.

Price Impact